Anne Haney Cross

Affiliations: 
Washington University School of Medicine, St. Louis, MO, United States 
Area:
multiple sclerosis, neuroimmunology, diffusion tensor imaging, experimental autoimmune encephalomyelitis
Google:
"Anne Cross"
Mean distance: 18.48 (cluster 46)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jiang H, Zhou C, Qiu L, et al. (2023) Quantitative Analysis of S1PR1 Expression in the Postmortem Multiple Sclerosis Central Nervous System. Acs Chemical Neuroscience. 14: 4039-4050
Cantoni C, Ghezzi L, Choi J, et al. (2023) Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 76: 104839
Williams MJ, Okai AF, Cross AH, et al. (2023) Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial. Multiple Sclerosis and Related Disorders. 76: 104794
Samara A, Cantoni C, Piccio L, et al. (2023) Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection. Multiple Sclerosis and Related Disorders. 76: 104768
Brier MR, Li Z, Ly M, et al. (2023) "Brain age" predicts disability accumulation in multiple sclerosis. Annals of Clinical and Translational Neurology
Brier MR, Xiang B, Ciotti JR, et al. (2023) Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD. Multiple Sclerosis and Related Disorders. 73: 104659
Ghezzi L, Bollman B, De Feo L, et al. (2023) Schwann Cell Remyelination in the Multiple Sclerosis Central Nervous System. Laboratory Investigation; a Journal of Technical Methods and Pathology. 100128
Xiang B, Wen J, Schmidt RE, et al. (2022) Evaluating brain damage in multiple sclerosis with simultaneous multi-angular-relaxometry of tissue. Annals of Clinical and Translational Neurology
Longbrake EE, Hua LH, Mowry EM, et al. (2022) The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome. Multiple Sclerosis and Related Disorders. 68: 104143
Aloisi F, Cross AH. (2022) MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis. Journal of Neuroimmunology. 371: 577935
See more...